Market closedNon-fractional

Natera/NTRA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Natera

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Ticker

NTRA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Austin, United States

Employees

3,288

Natera Metrics

BasicAdvanced
$13B
Market cap
-
P/E ratio
-$3.12
EPS
1.38
Beta
-
Dividend rate
$13B
1.38
4.123
3.83
43.751
55.382
-30.10%
-17.14%
-50.59%
10.237
16.21
16.21
-62.651
39.26%
-41.53%
39.07%
0.06%

What the Analysts think about Natera

Analyst Ratings

Majority rating from 17 analysts.
Buy

Natera Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-18.35% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$368M
18.19%
Net income
-$68M
-13.46%
Profit margin
-18.35%
-26.80%

Natera Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 20.60%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.97
-$0.95
-$0.64
-$0.56
-
Expected
-$1.09
-$0.96
-$0.73
-$0.71
-$0.69
Surprise
-11.35%
-0.60%
-12.03%
-20.60%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Natera stock?

Natera (NTRA) has a market cap of $13B as of July 23, 2024.

What is the P/E ratio for Natera stock?

The price to earnings (P/E) ratio for Natera (NTRA) stock is 0 as of July 23, 2024.

Does Natera stock pay dividends?

No, Natera (NTRA) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Natera dividend payment date?

Natera (NTRA) stock does not pay dividends to its shareholders.

What is the beta indicator for Natera?

Natera (NTRA) has a beta rating of 1.38. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Natera stock

Buy or sell Natera stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing